{"mainPropery":{"diseaseId":10791,"diseaseName":"Logopenic progressive aphasia","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10791/logopenic-progressive-aphasia","synonyms":["LPA","Logopenic primary progressive aphasia","Logopenic variant PPA"],"synonyms-with-source":[{"name":"LPA"},{"name":"Logopenic primary progressive aphasia"},{"name":"Logopenic variant PPA"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"250831"}]},"diseaseCategories":[{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":291,"resourceName":"National Aphasia Association","abbreviation":"","address1":"P.O. Box 87","address2":"","address3":"","address4":"","address5":"","city":"Scarsdale","state":"NY","zip":"10583","country":"United States","phone":"","tty":"","tollFree":"","fax":"","email":"naa@aphasia.org","url":"https://www.aphasia.org/","freeText":""},{"resourceID":532,"resourceName":"Association for Frontotemporal Degeneration","abbreviation":"AFTD","address1":"2700 Horizon Drive, Suite 120","address2":"","address3":"","address4":"","address5":"","city":"King of Prussia","state":"PA","zip":"19406","country":"United States","phone":"+1-267-514-7221","tty":"","tollFree":"1-866-507-7222","fax":"","email":"info@theaftd.org","url":"https://www.theaftd.org/","freeText":""},{"resourceID":738,"resourceName":"Aphasia Hope Foundation","abbreviation":"","address1":"750 Woodlands Pkwy","address2":"","address3":"","address4":"","address5":"","city":"Ridgeland","state":"MS","zip":"39157","country":"United States","phone":"(913)-484-8302","tty":"","tollFree":"","fax":"","email":"jstradinger.2007@comcast.net","url":"http://aphasiahope.wpengine.com/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=%22Logopenic%20progressive%20aphasia%22' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Logopenic progressive aphasia. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Logopenic+progressive+aphasia%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Logopenic progressive aphasia. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022485' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=250831' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2056,"resourceId":291,"resourceName":"National Aphasia Association","descriptionText":"The <a href='http://www.aphasia.org/aphasia-resources/primary-progressive-aphasia/' target='_blank'>National Aphasia Association</a> provides information on primary progressive aphasia and Logopenic progressive aphasia","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:250831' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":5278,"questionText":"What is logopenic progressive aphasia?","answerText":"<strong>Logopenic progressive aphasia (LPA)</strong> is a type of dementia characterized by&nbsp;language disturbance, including difficulty making or understanding speech (<a href=\"http://www.nlm.nih.gov/medlineplus/aphasia.html\" target=\"_blank\">aphasia</a>). It&nbsp;is a type of <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/8541/Primary_progressive_aphasia.aspx\" target=\"_blank\">primary progressive aphasia</a>&nbsp;(PPA). Affected individuals have slow, hesitant speech due to difficulty retrieving the correct words, names, or numbers. Difficulty with phase and sentence repetition are additionally present. Speech is typically well articulated and grammatically correct&nbsp;with good single-word comprehension. But over time, affected individuals may have trouble understanding long or complex verbal information, due to problems holding onto lengthy information that they hear.&nbsp;Language difficulties associated with LPA are due to shrinking, or atrophy, in the left posterior temporal cortex and inferior parietal lobule. <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/9549.htm\" target=\"_blank\">Click here</a> to view an image of the lobes of the brain.[4330][11126][11127]<br />","dateModified":"2013-01-18T13:18:00"},"basicQuestions":[{"questionId":6686,"questionText":"How might logopenic progressive aphasia be treated?","answerText":"Although no medications or interventions have demonstrated long-term stabilization of logopenic progressive aphasia (LPA), different treatment methods have shown promising short-term benefits.[11126][5776] Studies utilizing language therapy and behavioral interventions have shown encouraging results. Neuromodulation through methodologies such as&nbsp;<a href=\"http://www.hopkinsmedicine.org/psychiatry/specialty_areas/brain_stimulation/tdcs.html\" target=\"_blank\">Transcranial Direct Current Stimulation</a> (tDCS) and <a href=\"http://www.mayoclinic.org/tests-procedures/transcranial-magnetic-stimulation/home/ovc-20163795\" target=\"_blank\">transcranial magnetic stimulation</a>&nbsp;(rTMS) have additionally been identified as a promising therapies to potentially use in combination with behavioral treatment and language therapy.[11126]<br />\r\n<br />\r\nAs the most common underlying pathology of LPA is Alzheimer's disease (AD) pathology, limited research has been completed on interventions shown to reduce the rate of decline in cognitive symptoms in AD. So far&nbsp;<a href=\"http://www.alz.org/alzheimers_disease_standard_prescriptions.asp#cholinesterase\" target=\"_blank\">cholinesterase inhibitors</a>&nbsp;and <a href=\"http://www.alz.org/alzheimers_disease_standard_prescriptions.asp#memantine\" target=\"_blank\">memantine</a>,&nbsp;medications used in Alzheimer&rsquo;s disease, have not been proven effective in treating logopenic progressive aphasia. Case studies involving <a href=\"https://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">steriod</a> use and <a href=\"http://emedicine.medscape.com/article/1892957-technique\" target=\"_blank\">Omentum Transposition Therapy</a> have reported improvement; however, the results have not been replicated in other cases and as with other treatment options, long-term studies are lacking.[11126]\r\n<br />\r\n<br />\r\nThe National Aphasia Association provides further information on the medical management of <a href=\"http://www.rarediseases.info.nih.gov/GARD/Condition/8541/Primary_progressive_aphasia.aspx\" target=\"_blank\">primary progressive aphasias</a>&nbsp;at the following link:<a href=\"https://www.aphasia.org/aphasia-resources/aphasia-therapy-guide/\" target=\"_blank\"><br />\r\nhttps://www.aphasia.org/aphasia-resources/aphasia-therapy-guide/</a>","dateModified":"2016-04-04T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":5776,"authors":"Beeson PM, King RM, Bonakdarpour B, Henry ML, Cho H, Rapcsak SZ","articleTitle":"Positive effects of language treatment for the logopenic variant of primary progressive aphasia","bookWebsiteJournalTitle":"J Mol Neurosci","date":"2011 Nov;45(3):724-36","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/21710364","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11126,"authors":"Donna C. Tippett, Argye E. Hillis,Kyrana Tsapkini","articleTitle":"Treatment of Primary Progressive Aphasia","bookWebsiteJournalTitle":"Curr Treat Options Neurol.","date":"August 2015","volume":"17(8)","pages":"362","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600091/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":6687,"questionText":"What is the typical life expectancy for people with logopenic progressive aphasia?","answerText":"Little is known regarding the overall life expectancy of individuals with logopenic progressive aphasia. This dementia is associated with Alzheimer’s disease in the majority of cases.[5779] Life expectancy for people with Alzheimer’s disease has been estimated to be between 3 to 10 years.[5780] However, due to the many variables that influence life expectancy, making individualized life-expectancy predictions can be very difficult.","dateModified":"2013-01-18T15:10:00","resourceClassificationName":"Prognosis","references":[{"referenceId":5775,"authors":"Miller BL Lee SE,","articleTitle":"Frontotemporal dementia: Treatment","bookWebsiteJournalTitle":"UpToDate","date":"2013","authors2":"DeKosky ST, Eichler AF","placeOfPublication":"Waltham, MA","publisher":"UpToDate"},{"referenceId":5776,"authors":"Beeson PM, King RM, Bonakdarpour B, Henry ML, Cho H, Rapcsak SZ","articleTitle":"Positive effects of language treatment for the logopenic variant of primary progressive aphasia","bookWebsiteJournalTitle":"J Mol Neurosci","date":"2011 Nov;45(3):724-36","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/21710364","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5777,"authors":"Le Rhun E, Richard F, Pasquier F","articleTitle":"Natural history of primary progressive aphasia","bookWebsiteJournalTitle":"Neurology","date":"2005 Sep 27;65(6):887-91","url":"http://www.ncbi.nlm.nih.gov/pubmed/16186529","dateAccessed":"2013-01-18T00:00:00"},{"referenceId":5778,"authors":"Amici S, Gorno-Tempini ML, Ogar JM, Dronkers NF, Miller BL","articleTitle":"An overview on Primary Progressive Aphasia and its variants","bookWebsiteJournalTitle":"Behav Neurol","date":"2006;17(2):77-87","url":"http://www.ncbi.nlm.nih.gov/pubmed/16873918","dateAccessed":"2013-01-18T00:00:00"},{"referenceId":5779,"authors":"Hsieh S, Hodges JR, Leyton CE, Mioshi E","articleTitle":"Longitudinal changes in primary progressive aphasias: differences in cognitive and dementia staging measures","bookWebsiteJournalTitle":"Dement Geriatr Cogn Disord","date":"2012;34(2):135-41","url":"http://www.ncbi.nlm.nih.gov/pubmed/23006977","dateAccessed":"2013-01-18T00:00:00"},{"referenceId":5780,"authors":"Zanetti O, Solerte SB, Cantoni F","articleTitle":"Life expectancy in Alzheimer's disease (AD)","bookWebsiteJournalTitle":"Arch Gerontol Geriatr","date":"2009;49 Suppl 1:237-43","url":"http://www.ncbi.nlm.nih.gov/pubmed/19836639","dateAccessed":"2013-01-18T00:00:00"},{"referenceId":5781,"authors":"Randolph C ","articleTitle":"Frontotermporal dementia: Clinical features and diganosis","bookWebsiteJournalTitle":"UpToDate","date":"2012","authors2":"DeKasky ST, Eichler AF","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":6688,"questionText":"What is the prognosis for people with logopenic progressive aphasia?","answerText":"Typically during the first few years following disease onset, signs and symptoms primarily involve&nbsp;speech and language problems. Pronounced behavioral problems are not as common in logopenic progressive aphasia, as in other forms of primary progressive aphasia.[5777] Caregiver experience of changes in behavioral symptoms and everyday skills has been demonstrated to be similar to that of Alzheimer’s disease.[5779]","dateModified":"2013-01-18T15:39:00","resourceClassificationName":"Prognosis","references":[{"referenceId":5775,"authors":"Miller BL Lee SE,","articleTitle":"Frontotemporal dementia: Treatment","bookWebsiteJournalTitle":"UpToDate","date":"2013","authors2":"DeKosky ST, Eichler AF","placeOfPublication":"Waltham, MA","publisher":"UpToDate"},{"referenceId":5776,"authors":"Beeson PM, King RM, Bonakdarpour B, Henry ML, Cho H, Rapcsak SZ","articleTitle":"Positive effects of language treatment for the logopenic variant of primary progressive aphasia","bookWebsiteJournalTitle":"J Mol Neurosci","date":"2011 Nov;45(3):724-36","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/21710364","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5777,"authors":"Le Rhun E, Richard F, Pasquier F","articleTitle":"Natural history of primary progressive aphasia","bookWebsiteJournalTitle":"Neurology","date":"2005 Sep 27;65(6):887-91","url":"http://www.ncbi.nlm.nih.gov/pubmed/16186529","dateAccessed":"2013-01-18T00:00:00"},{"referenceId":5778,"authors":"Amici S, Gorno-Tempini ML, Ogar JM, Dronkers NF, Miller BL","articleTitle":"An overview on Primary Progressive Aphasia and its variants","bookWebsiteJournalTitle":"Behav Neurol","date":"2006;17(2):77-87","url":"http://www.ncbi.nlm.nih.gov/pubmed/16873918","dateAccessed":"2013-01-18T00:00:00"},{"referenceId":5779,"authors":"Hsieh S, Hodges JR, Leyton CE, Mioshi E","articleTitle":"Longitudinal changes in primary progressive aphasias: differences in cognitive and dementia staging measures","bookWebsiteJournalTitle":"Dement Geriatr Cogn Disord","date":"2012;34(2):135-41","url":"http://www.ncbi.nlm.nih.gov/pubmed/23006977","dateAccessed":"2013-01-18T00:00:00"},{"referenceId":5780,"authors":"Zanetti O, Solerte SB, Cantoni F","articleTitle":"Life expectancy in Alzheimer's disease (AD)","bookWebsiteJournalTitle":"Arch Gerontol Geriatr","date":"2009;49 Suppl 1:237-43","url":"http://www.ncbi.nlm.nih.gov/pubmed/19836639","dateAccessed":"2013-01-18T00:00:00"},{"referenceId":5781,"authors":"Randolph C ","articleTitle":"Frontotermporal dementia: Clinical features and diganosis","bookWebsiteJournalTitle":"UpToDate","date":"2012","authors2":"DeKasky ST, Eichler AF","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":8541,"relatedDiseaseName":"Primary progressive aphasia","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":37804,"abbreviatedInquiry":"Two questions if I may: Is there any know medications or treatment that can be used for this condition? What can the life expectancy be?&nbsp;","caseQuestions":[{"questionId":6687,"questionText":"What is the typical life expectancy for people with logopenic progressive aphasia?","answerText":"Little is known regarding the overall life expectancy of individuals with logopenic progressive aphasia. This dementia is associated with Alzheimer’s disease in the majority of cases.[5779] Life expectancy for people with Alzheimer’s disease has been estimated to be between 3 to 10 years.[5780] However, due to the many variables that influence life expectancy, making individualized life-expectancy predictions can be very difficult.","dateModified":"2013-01-18T15:10:00","resourceClassificationName":"Prognosis","references":[{"referenceId":5775,"authors":"Miller BL Lee SE,","articleTitle":"Frontotemporal dementia: Treatment","bookWebsiteJournalTitle":"UpToDate","date":"2013","authors2":"DeKosky ST, Eichler AF","placeOfPublication":"Waltham, MA","publisher":"UpToDate"},{"referenceId":5776,"authors":"Beeson PM, King RM, Bonakdarpour B, Henry ML, Cho H, Rapcsak SZ","articleTitle":"Positive effects of language treatment for the logopenic variant of primary progressive aphasia","bookWebsiteJournalTitle":"J Mol Neurosci","date":"2011 Nov;45(3):724-36","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/21710364","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5777,"authors":"Le Rhun E, Richard F, Pasquier F","articleTitle":"Natural history of primary progressive aphasia","bookWebsiteJournalTitle":"Neurology","date":"2005 Sep 27;65(6):887-91","url":"http://www.ncbi.nlm.nih.gov/pubmed/16186529","dateAccessed":"2013-01-18T00:00:00"},{"referenceId":5778,"authors":"Amici S, Gorno-Tempini ML, Ogar JM, Dronkers NF, Miller BL","articleTitle":"An overview on Primary Progressive Aphasia and its variants","bookWebsiteJournalTitle":"Behav Neurol","date":"2006;17(2):77-87","url":"http://www.ncbi.nlm.nih.gov/pubmed/16873918","dateAccessed":"2013-01-18T00:00:00"},{"referenceId":5779,"authors":"Hsieh S, Hodges JR, Leyton CE, Mioshi E","articleTitle":"Longitudinal changes in primary progressive aphasias: differences in cognitive and dementia staging measures","bookWebsiteJournalTitle":"Dement Geriatr Cogn Disord","date":"2012;34(2):135-41","url":"http://www.ncbi.nlm.nih.gov/pubmed/23006977","dateAccessed":"2013-01-18T00:00:00"},{"referenceId":5780,"authors":"Zanetti O, Solerte SB, Cantoni F","articleTitle":"Life expectancy in Alzheimer's disease (AD)","bookWebsiteJournalTitle":"Arch Gerontol Geriatr","date":"2009;49 Suppl 1:237-43","url":"http://www.ncbi.nlm.nih.gov/pubmed/19836639","dateAccessed":"2013-01-18T00:00:00"},{"referenceId":5781,"authors":"Randolph C ","articleTitle":"Frontotermporal dementia: Clinical features and diganosis","bookWebsiteJournalTitle":"UpToDate","date":"2012","authors2":"DeKasky ST, Eichler AF","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":6686,"questionText":"How might logopenic progressive aphasia be treated?","answerText":"Although no medications or interventions have demonstrated long-term stabilization of logopenic progressive aphasia (LPA), different treatment methods have shown promising short-term benefits.[11126][5776] Studies utilizing language therapy and behavioral interventions have shown encouraging results. Neuromodulation through methodologies such as&nbsp;<a href=\"http://www.hopkinsmedicine.org/psychiatry/specialty_areas/brain_stimulation/tdcs.html\" target=\"_blank\">Transcranial Direct Current Stimulation</a> (tDCS) and <a href=\"http://www.mayoclinic.org/tests-procedures/transcranial-magnetic-stimulation/home/ovc-20163795\" target=\"_blank\">transcranial magnetic stimulation</a>&nbsp;(rTMS) have additionally been identified as a promising therapies to potentially use in combination with behavioral treatment and language therapy.[11126]<br />\r\n<br />\r\nAs the most common underlying pathology of LPA is Alzheimer's disease (AD) pathology, limited research has been completed on interventions shown to reduce the rate of decline in cognitive symptoms in AD. So far&nbsp;<a href=\"http://www.alz.org/alzheimers_disease_standard_prescriptions.asp#cholinesterase\" target=\"_blank\">cholinesterase inhibitors</a>&nbsp;and <a href=\"http://www.alz.org/alzheimers_disease_standard_prescriptions.asp#memantine\" target=\"_blank\">memantine</a>,&nbsp;medications used in Alzheimer&rsquo;s disease, have not been proven effective in treating logopenic progressive aphasia. Case studies involving <a href=\"https://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">steriod</a> use and <a href=\"http://emedicine.medscape.com/article/1892957-technique\" target=\"_blank\">Omentum Transposition Therapy</a> have reported improvement; however, the results have not been replicated in other cases and as with other treatment options, long-term studies are lacking.[11126]\r\n<br />\r\n<br />\r\nThe National Aphasia Association provides further information on the medical management of <a href=\"http://www.rarediseases.info.nih.gov/GARD/Condition/8541/Primary_progressive_aphasia.aspx\" target=\"_blank\">primary progressive aphasias</a>&nbsp;at the following link:<a href=\"https://www.aphasia.org/aphasia-resources/aphasia-therapy-guide/\" target=\"_blank\"><br />\r\nhttps://www.aphasia.org/aphasia-resources/aphasia-therapy-guide/</a>","dateModified":"2016-04-04T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":5776,"authors":"Beeson PM, King RM, Bonakdarpour B, Henry ML, Cho H, Rapcsak SZ","articleTitle":"Positive effects of language treatment for the logopenic variant of primary progressive aphasia","bookWebsiteJournalTitle":"J Mol Neurosci","date":"2011 Nov;45(3):724-36","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/21710364","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11126,"authors":"Donna C. Tippett, Argye E. Hillis,Kyrana Tsapkini","articleTitle":"Treatment of Primary Progressive Aphasia","bookWebsiteJournalTitle":"Curr Treat Options Neurol.","date":"August 2015","volume":"17(8)","pages":"362","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600091/","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Logopenic_progressive_aphasia"}